(Q35802744)

10 August 2017

Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service (English)

1 reference

10 August 2017

1 reference

R G Morris

1

1 reference

10 August 2017

A B Black

2

1 reference

10 August 2017

A L Harris

3

1 reference

10 August 2017

A B Batty

4

1 reference

10 August 2017

B C Sallustio

5

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

46

1 reference

10 August 2017

6

1 reference

10 August 2017

547-551

1 reference

High-performance liquid chromatography quantitation of plasma lamotrigine concentrations: application measuring trough concentrations in patients with epilepsy

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873793

Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873793

Pharmacokinetic interactions of the new antiepileptic drugs

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873793

Influence of concurrent antiepileptic medication on the pharmacokinetics of lamotrigine as add-on therapy in epileptic children

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873793

Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873793

Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873793

Lamotrigine versus other antiepileptic drugs: a star rating system is born

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873793

Lamotrigine: an antiepileptic agent for the treatment of partial seizures

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873793

Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873793

A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873793

Clinical pharmacology of lamotrigine

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873793

Sodium valproate acutely inhibits lamotrigine metabolism

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873793

An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873793

Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873793

The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy

25 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1998.00835.X

Acute effects of lamotrigine (BW430C) in persons with epilepsy

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Outcomes of add-on treatment with lamotrigine in partial epilepsy

1 reference

12 December 2020

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

1 reference

12 December 2020

Concentration--effect and concentration--toxicity relations with lamotrigine: a prospective study

1 reference

12 December 2020

Combination vigabatrin and lamotrigine therapy for intractable epilepsy

1 reference

12 December 2020

Lamotrigine high-dose tolerability and safety in patients with epilepsy: a double-blind, placebo-controlled, eleven-week study

1 reference

12 December 2020

Lamotrigine Plasma Concentrations in Children and Adults

1 reference

12 December 2020

Survey of cyclosporine therapeutic ranges, assay methodology, and use of 'sparing agents' in Australasian transplant centers

1 reference

12 December 2020

10.1046/J.1365-2125.1998.00835.X

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

9862243

1 reference